EMA's Orphan Drug Program Update Looking At Similarity Standard
This article was originally published in The Pink Sheet Daily
Executive Summary
EMA can't approve a similar product during an orphan drug's 10-year exclusivity period, but some criteria for that determination have not been officially defined.